Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Research Article Volume 5 Issue 3

Improvement of Primary Dysmenorrhea with Oral Dose of Vitamin D: A Pilot Study

Manuel Garcia Manero1*, Nicolas Garcia Goyenecha2, Miguel Alvarez2 and Itaxo Salinas2

1Centro De Trabajo, Hospital Garcia Orcoyen (SNS-Osasunbidea), Spain
2Facultad De Medicina, Universidad de Navarra, Spain

*Corresponding Author: Manuel Garcia Manero, Centro De Trabajo, Hospital Garcia Orcoyen (SNS-Osasunbidea), Spain.

Received: December 13, 2022; Published: February 05, 2023


Primary dysmenorrhea is a common disorder characterized by painful uterine cramping, just before or during menstruation, in the absence of any pelvic pathologic conditions. It is frequently accompanied by other symptoms such as nausea, vomiting, diarrhea, asthenia, and insomnia.

An excessive uterine production of prostaglandins (PGs) is the pathogenetic trigger of dysmenorrhea. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the currently accepted drugs for the management of this disorder.

Because the vitamin D receptor is widespread and the mitochondrial cytochrome P450 enzyme 25-hydroxyvitamin D3 (25[OH]D)-1α-hydroxylase (1α-OHase), which catalyzes the synthesis of 1α,25-dihydroxyvitamin D3 (1,25[OH]2D) from its precursor 25(OH)D, is expressed in the human uterus and in immune system cells, and because vitamin D reduces the synthesis of PGs, a beneficial effect of vitamin D in the uterus pathophysiology is possible.

We evaluated the effect of vitamin D supplementation on individuals in 3 categories: individuals with mild dysmenorrhea; moderate dysmenorrhea and severe dysmenorrhea.

The aim of this intervention study was to evaluate the effect of oral dose of cholecalciferol (2 000 IU) on primary dysmenorrhea

Keywords: Vitamin D; Dysmenorrhea


  1. Bahrami A., et al. “Menstrual disorders and premenstrual symptoms in adolescents: prevalence and relationship to serum calcium and vitamin D concentrations”. Journal of Obstetrics and Gynaecology 7 (2018): 989-995.
  2. Binabaj MM., et al. “The prognostic value of MGMT promoter methylation in glioblastoma: a meta-analysis of clinical trials”. Journal of Cell Physiology1 (2018): 378-386.
  3. Klein JR and IF Litt. “Epidemiology of adolescent dysmenorrhea”. Pediatrics5 (1981): 661-664.
  4. Freeman EW. “Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis”. Psychoneuroendocrinology 28 (2003): 25-37.
  5. Menon V., et al. “Vitamin D and depression: a critical appraisal of the evidence and future directions”. Indian Journal of Psychological Medicine1 (2020): 11-21.
  6. Makrani AH., et al. “Vitamin D and fibromyalgia: a meta-analysis”. Korean Journal of Pain4 (2017): 250.
  7. Corachán A., et al. “Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation”. Fertility and Sterility2 (2021): 512-521.
  8. Moini A., et al. “The effect of vitamin D on primary dysmenorrhea with vitamin D deficiency: a Randomized double-blind controlled clinical trial”. Gynecology and Endocrinology6 (2016): 502-505.
  9. Zarei S., et al. “Effects of calcium-Vitamin D and calcium-alone on pain intensity and menstrual blood loss in women with primary dysmenorrhea: A randomized controlled trial”. Pain Medicine1 (2017): 3-13.
  10. Zangane M., et al. “Evaluation of the effects of oral vitamin-D for pelvic pain reduction in primary dysmenorrhea”. IJOGI88 (2014): 14-20.
  11. Jukic AMZ., et al. “Increasing serum 25-hydroxyvitamin D is associated with reduced odds of long menstrual cycles in a cross-sectional study of African American women”. Fertility and Sterility1 (2016): 172-179. e2.
  12. Lasco A., et al. “Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, doubleblind, placebo-controlled study”. Archives of Internal Medicine4 (2012): 366-367.
  13. Abdul-Razzak KK., et al. “Vitamin D and PTH status among adolescent and young females with severe dysmenorrhea”. Journal of Pediatric and Adolescent Gynecology 2 (2014): 78-82.
  14. Lerchbaum E., et al. “Mechanisms in endocrinology: vitamin D and fertility: a systematic review”. European Journal of Endocrinology5 (2012): 765-778.
  15. Vigano P., et al. “Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system”. Journal of Molecular Endocrinology 3 (2006): 415-424.
  16. Karacin O., et al. “Serum vitamin D concentrations in young Turkish women with primary dysmenorrhea : a randomized controlled study”. Taiwanese Journal of Obstetrics and Gynecology 1 (2018): 58-63.


Citation: Manuel Garcia Manero., et al. “Improvement of Primary Dysmenorrhea with Oral Dose of Vitamin D: A Pilot Study". Acta Scientific Women's Health 5.3 (2023): 18-23.


Copyright: © 2022 Manuel Garcia Manero., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US